Jeff June is the founder and CEO of IschemiaCare. Jeff comes from a background in venture capital and private equity, and held the Forsythe Chair in Entrepreneurship at Miami University of Ohio.
Top 3 Takeaways
- In 40% of stroke cases, the specific cause is unknown.
- Stroke care can benefit from greater diagnostic personalization.
- Having the right people in your life and on your team is an outsized advantage.
Show Notes
- [1:00] Jeff’s background.
- [2:45] Origin of IschemiaCare.
- [5:52] What IschemiaCare does.
- [8:05] A-fib stroke.
- [10:20] How IschemiaCare gains usage.
- [13:30] IschemiaCare’s business model.
- [15:20] Growth plan.
- [16:00] IschemiaCare’s product and how it fits into stroke care pipeline.
- [17:50] The RNA data play.
- [19:40] Extrapolating data insights.
- [23:40] Key lessons about healthtech.
- [27:30] Reminding people of your mission.
- [30:00] Doug’s meme on the Loup website.